Clinical trial
Chemosensitization With Plerixafor Plus G-CSF in Relapsed or Refractory Acute Myeloid Leukemia
NCT00906945 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chemosensitization With Plerixafor Plus G-CSF in Relapsed or Refractory Acute Myeloid Leukemia
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- September 30, 2015
- Enrollment
- 39 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.